A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance. (2017)
Attributed to:
Tropical Infectious Disease Consortium: Expanding and Accelerating Product
Development
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/ncomms15159
PubMed Identifier: 28537265
Publication URI: http://europepmc.org/abstract/MED/28537265
Type: Journal Article/Review
Volume: 8
Parent Publication: Nature communications
ISSN: 2041-1723